Nutrien stock drops 15% despite strong cash flow

The fertilizer giant missed earnings expectations but its core business remains solid, suggesting a buying opportunity.

8 cards · 2m · tap to begin

From · · · 2m

Nutrien stock drops 15% despite strong cash flow

The fertilizer giant missed earnings expectations but its core business remains solid, suggesting a buying opportunity.

In brief

The fertilizer giant missed earnings expectations but its core business remains solid, suggesting a buying opportunity. Nutrien's earnings miss masks underlying operational strength in potash and retail, with strong cash generation and strategic reviews that could unlock shareholder value. Originally reported by…

Nutrien misses earnings despite revenue growth

The fertilizer company reported Q2 2026 earnings of $2.53 per share, falling short of analyst expectations of $2.91. Revenue grew 3.6% year-over-year to $10.8 billion, but rising costs compressed profits.

Potash division hits record volumes

Potash delivered record sales volumes in the first half of 2026 with a 53% automation rate in ore mining, surpassing 2024 targets. Global potash shipments are forecast between 74 and 77 million tonnes for the year.

Phosphate and nitrogen face margin pressure

Phosphate and nitrogen face margin pressure

The phosphate segment struggles with elevated sulfur costs creating unsustainable margin pressure. Nitrogen division locked in 85% of Q3 sales volumes at summer pricing, protecting margins ahead of seasonal demand.

“unsustainable pressure on global phosphate producer margins”

Retail segment shows structural growth

Retail adjusted EBITDA declined 2% to $1.131 billion despite a 4% sales increase to $8.270 billion. Proprietary products margins expanded in the United States and Australia, offsetting higher fuel costs.

Strong cash generation supports dividends

Q2 operating cash flow reached $2.5 billion with first-half adjusted EBITDA up 6% year-over-year to $3.5 billion. The company increased its quarterly dividend by 1% to $0.55 per share and accelerated share buybacks to $75 million monthly.

Stock trades below analyst targets

Nutrien trades at $74.43 with a forward P/E of 14.02x, below the median analyst target of $82.00. Recent downgrades from National Bank and Morgan Stanley reflect near-term concerns rather than fundamental deterioration.

Strategic reviews could unlock value

Management is reviewing the phosphate business and Trinidad nitrogen operations with conclusions expected by year-end 2026. Multiple nonbinding bids for the phosphate business suggest potential portfolio optimization and reduced exposure to sulfur cost pressures.

Investor Day and Q3 earnings ahead

Nutrien will host an Investor Day on November 30, 2026 in Toronto to outline growth initiatives. Q3 earnings on November 4, 2026 will provide critical visibility into nitrogen margins and retail momentum, with analysts projecting $0.90 EPS.

The big picture

Nutrien's earnings miss masks underlying operational strength in potash and retail, with strong cash generation and strategic reviews that could unlock shareholder value.

Read the original on Alphastreet - Earnings Decoded. Market Intelligence Delivered

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on nutrien and related topics.